Montelukast Prescribing at PRIMROSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
933
Total Quantity
23.0K
NHS Cost
£1.4K
vs National Avg
+36.3%
PRIMROSE SURGERY prescribed 933 items of Montelukast over the last 12 months at a cost of £1,448 to the NHS. This is 36.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
79
Jun 2026
67
Jun 2026
81
Jun 2026
63
Jun 2026
76
Jun 2026
84
Jun 2026
81
Jun 2026
73
Jun 2026
77
Jun 2026
80
Jun 2026
81
Jun 2026
91
Prescribing Details
| Total Items | 933 |
|---|---|
| Total Quantity | 23,028 |
| Total NHS Cost | £1,448 |
| Presentations | 5 different forms |
| vs National Average | +36.3% |
Montelukast Prescribing Comparison
| This practice | 933 items |
|---|---|
| National average per practice | 685 items |
| Difference | +36.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.